Skip to main content
Decorative image of a bridge span

Anchor Collaboratives: Building bridges with place-based partnerships and anchor institutions

Mobilizing anchor institutions Centering community and place

The Democracy Collaborative’s new report Anchor Collaboratives: Building Bridges with Place-Based Partnerships and Anchor Institutions discusses the role of anchor institutions and collaboratives in leveraging the power of their economic assets to address social and economic disparities and to revitalize local communities.

The report focuses on the work of anchor institutions and partner organizations that have joined to form place-based networks, or anchor collaboratives, to develop, implement, and support shared goals and initiatives that advance equitable and inclusive economic development strategies. Anchor mission work is not easy, but our hope is that this state of the field report will provide information and assistance to groups wanting to do anchor mission work or to create anchor collaboratives.

Publication date: 2019-05-07
Publisher: The Democracy Collaborative
Download and read now:

More related work

May 18, 2020
Digital infrastructure panel

Democratic digital infrastructure

The global spread of Covid-19 has shone a bright spotlight on both the vital need for reliable high-speed internet and the inadequacies of the for-profit, corporate model in delivering it. This paper, the first of four modules on democratic public ownership in the United Kingdom and the US, explores

read more
March 2, 2020
HAN's Anchor Mission Communications Toolkit

Healthcare Anchor Network's (HAN) Anchor Mission Communications Toolkit

The Anchor Mission Communications Toolkit provides communications tips, tools and examples from anchor institutions, to help with the work of communicating an anchor mission approach.

read more
An array of prescription medications on shelves

Medicine For All: The case for a public option in the pharmaceutical industry

Democratic, public ownership of pharmaceutical development, production, and distribution in the U.S. is necessary to combat the increasingly harmful impacts of Big Pharma which decades of regulation have failed to counteract.

read more